Information Provided By:
Fly News Breaks for February 16, 2017
CYNO, HOLX, AGN, ZLTQ
Feb 16, 2017 | 05:55 EDT
JPMorgan analyst Tycho Peterson reinstated ZELTIQ Aesthetics (ZLTQ) with a Neutral rating and $56.50 price target following a period of restriction. The analyst does not expect a competing takeover bid to Allergan's (AGN) to emerge, especially with Hologic (HOLX) recently acquiring Cynosure (CYNO).
News For ZLTQ;AGN;HOLX;CYNO From the Last 2 Days
There are no results for your query ZLTQ;AGN;HOLX;CYNO